US Clinical Chemistry and Immunodiagnostics Markets: Innovative Technologies and Emerging Business Opportunities
Upcoming SlideShare
Loading in...5
×

Like this? Share it with your network

Share

US Clinical Chemistry and Immunodiagnostics Markets: Innovative Technologies and Emerging Business Opportunities

  • 246 views
Uploaded on

 

  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
    Be the first to like this
No Downloads

Views

Total Views
246
On Slideshare
246
From Embeds
0
Number of Embeds
0

Actions

Shares
Downloads
0
Comments
0
Likes
0

Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
    No notes for slide

Transcript

  • 1. US Clinical Chemistry and Immunodiagnostics Markets:Innovative Technologies and Emerging Business OpportunitiesReport Details:Published:December 2012No. of Pages: 600Price: Single User License – US$10700This report provides a comprehensive analysis of the US clinical chemistry andimmunodiagnostics markets, including:Major issues pertaining to the US clinical chemistry and immunodiagnostic laboratory practice, aswell as key economic, regulatory, demographic, social and technological trends with significantmarket impact during the next ten years.Five- and ten-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine,cancer, immunoprotein and abused drug assays performed in US hospitals, commerciallaboratories, and physician offices, including controls, calibrators and consumables.Five- and ten-year volume forecasts for serum, whole blood, plasma, CFS, urine and otherspecimens.Five- and ten-year reagent and instrument sales forecasts.Review of current instrumentation technologies, and a feature comparison of 50 high-, medium-,and low-volume/POC analyzers.Sales and market shares of leading reagent and instrument suppliers.Review of current and emerging technologies and their potential market applications.Product development opportunities for clinical chemistry and immunodiagnostic instruments andconsumables.Profiles of 25 current and emerging suppliers, including their sales, market shares, productportfolios, marketing tactics, technological know-how, new products in R&D, collaborativearrangements and business strategies.Market penetration strategies, entry barriers and risks.Get your copy of this report @http://www.reportsnreports.com/reports/209679-us-clinical-chemistry-and-immunodiagnostics-markets-innovative-technologies-and-emerging-business-opportunities.htmlMajor points covered in Table of Contents of this report includeTable of Contents
  • 2. IntroductionWorldwide Market and Technology OverviewA. Major Routine Chemistry Tests1. Albumin2. Alkaline Phosphatase3. ALT/SGPT4. Ammonia5. Amylase6. AST/SGOT7. Bilirubin, Total8. Blood Gases9. Blood Urea Nitrogen (BUN)10. Calcium11. Cardio CRP12. Cholesterol13. Cholinesterase14. CRP15. Creatinine16. Electrolytesa. Carbon Dioxide/Bicarbonateb. Chloridec. Potassiumd. Sodium17. Ferritin18. Fructosamine19. Gamma-Glutamyl Transpeptidase (GGT)20. Glucose21. High Density Lipoprotein (HDL)22. Homocysteine23. Iron24. Lactate Dehydrogenase (LDH)25. Magnesium26. Phosphorus27. Protein28. Triglycerides29. Uric Acid30. TroponinB. Therapeutic Drug Monitoring (TDM)1. Overview2. Carbamazepine3. Cyclosporin4. Digoxin
  • 3. 5. Everolimus6. Gentamicin7. Lamotrigine/Lamictal8. Levetiracetam9. Lidocaine10. Lithium11. NAPA/Procainamide12. Phenytoin13. Quinidine14. Sirolimus15. Tacrolimus16. Theophylline17. Topirimate18. Valproic AcidC. Endocrine Function Tests1. Cortisol2. Follicle-Stimulating Hormone (FSH)3. Gastrin4. Growth Hormone/IGF-15. Human Chorionic Gonadotropin (HCG)6. LH7. PTH/IO PTH8. Prolactin9. T310. T3 Free11. T3 Uptake12. T4 (Thyroxine)13. T4 Free14. TBG15. Thyroglobulin Ab16. TPO Ab17. TSHD. Tumor Markers And Special Chemistry Tests1. AFP2. CA 15-33. CA 19-94. CA 27-295. Carcinoembrionic Antigen (CEA)6. Folate/Folic Acid7. HCG8. 25-Hydroxy Vitamin D2 and D39. Occult Blood
  • 4. 10. Prostate-Specific Antigen (PSA)11. Thyroglobulin12. Vitamin B-12E. Immunoprotein Tests1. Complementa. C3b. C42. Free Light Chains3. Immunofixation4. Immunoglobulins (IgA, IgE, IgG, IgM)5. Haptoglobin6. Prealbumin7. Protein ElectrophoresisF. Drugs of Abuse1. Overview2. Test Methodologies3. Amphetamines4. Barbiturates5. Benzodiazepines6. Cannabinoids/Marijuana7. Cocaine8. Lysergic Acid Diethylamide (LSD)9. Methadone10. Methaqualone11. Opiates12. Phencyclidine13. Tricyclic AntidepressantsG. Instrumentation Review: Operating Characteristics and Features of High-, Medium-, andLowVolume/POC Analyzers Manufactured By:AbaxisAbbottAlere/InvernessAlfa WassermannAMSAwareness TechnologiesBeckman Coulter/OlympusBinding SitebioMerieuxCarolina ChemistriesDiaSorinGrifolsHoriba
  • 5. MedicaNova BiomedicalOrtho-Clinical DiagnosticsPolymedcoRandoxRocheSiemensTosohVital DiagnosticsH. Major In Vitro Diagnostic Technologies And Their Potential Applications1. Monoclonal and Polyclonal Antibodies2. Immunoassaysa. Technological Principled. Chemiluminescencec. Enzyme Immunoassays (EIA)OverviewELISAEMITElectrochemicald. Radioimmunoassays (RIA)e. Immunoprecipitationf. Affinity Chromatography3. Tandem Mass Spec4. IT and Automation5. Dry Chemistry6. BiosensorsU.S.A.A. Executive SummaryB. Business Environment1. Health Care Expenditures2. Cost Consciousness3. Industry Consolidation4. Managed Care5. Hospitals6. Admissions7. Length of Stay8. Industry Diversification9. Physician Demographics10. Population Aginga. Chronic Illnessb. Disease Incidencec. Susceptibility to Iatrogenesis
  • 6. d. Multiple Illness Cases11. Laboratory RegulationsC. Market Structure1. Centralized Testinga. Hospitalsb. Commercial/Private Laboratories2. Decentralized Testinga. Physician Offices/Group Practicesb. Point-of-Care Testingc. Home/Self Testingd. Other Decentralized Testing LocationsD. Market Size, Growth and Major Suppliers Instrument and Reagent Sales and Market SharesMajor Product Development OpportunitiesDesign Criteria for Decentralized Testing ProductsAlternative Market Penetration StrategiesA. Internal DevelopmentB. Collaborative ArrangementsC. University ContractsD. Distribution Strategies for Decentralized Testing Markets1. Marketing Approaches2. Product Complexity3. Customer Preference4. Established Suppliers5. Emerging Suppliers6. Major Types of Distributors7. Market SegmentationPotential Market Entry Barriers and RisksA. Market MaturityB. Cost ContainmentC. CompetitionD. Technological Edge and LimitationsE. Patent ProtectionF. Regulatory ConstraintsG. Decentralized Testing Market ChallengesCompetitive AssessmentsAbbott LaboratoriesAdnaGenBeckman Coulter/DanaherBiomedical DiagnosticsBioMerieuxBio-RadDako
  • 7. DiaSorinEikenFujirebioInstrumentation LaboratoryKyowa MedexMatritechOrtho-Clinical DiagnosticsRocheSiemensSysmexThermo FisherTosohWakoWallac/PEList of TablesMajor Companies Developing or Marketing Albumin TestsMajor Companies Developing or Marketing Alkaline Phosphatase TestsMajor Companies Developing or Marketing ALT/SGPT TestsMajor Companies Developing or Marketing Amylase TestsMajor Companies Developing or Marketing AST/SGOT TestsMajor Companies Developing or Marketing Bilirubin TestsMajor Companies Developing or Marketing Blood Gas AnalyzersMajor Companies Developing or Marketing BUN TestsMajor Companies Developing or Marketing Calcium TestsMajor Companies Developing or Marketing Cholesterol TestsMajor Companies Developing or Marketing Creatinine TestsMajor Companies Developing or Marketing Electrolyte TestsMajor Companies Developing or Marketing GGT TestsMajor Companies Developing or Marketing Glucose TestsMajor Companies Developing or Marketing HDL TestsMajor Companies Developing or Marketing Iron TestsMajor Companies Developing or Marketing LDH TestsMajor Companies Developing or Marketing Magnesium TestsMajor Companies Developing or Marketing Phosphorus TestsMajor Companies Developing or Marketing Protein TestsMajor Companies Developing or Marketing Triglycerides TestsMajor Companies Developing or Marketing Uric Acid TestsMajor Companies Developing or Marketing TDM TestsMajor Companies Developing or Marketing Digoxin TestsMajor Companies Developing or Marketing Lithium TestsMajor Companies Developing or Marketing Phenytoin/Dilantin TestsMajor Companies Developing or Marketing Theophylline Tests
  • 8. Major Companies Developing or Marketing Valproic Acid TestsMajor Companies Developing or Marketing FSH TestsMajor Companies Developing or Marketing HCG TestsMajor Companies Developing or Marketing LH TestsMajor Companies Developing or Marketing Prolactin TestsMajor Companies Developing or Marketing T3 TestsMajor Companies Developing or Marketing T4 TestsMajor Companies Developing or Marketing TSH TestsMajor Companies Developing or Marketing AFP TestsMajor Companies Developing or Marketing CEA TestsMajor Companies Developing or Marketing Ferritin TestsMajor Companies Developing or Marketing Occult Blood TestsMajor Companies Developing or Marketing Prostatic Acid Phosphatase TestsMajor Companies Developing or Marketing PSA TestsMajor Companies Developing or Marketing Vitamin B-12/Folate TestsMajor Companies Developing or Marketing CRP TestsMajor Companies Developing or Marketing Drugs of Abuse TestsMajor Companies Developing or Marketing Biosensors for Immunological TestingExecutive Summary Table: U.S.A., Clinical Chemistry and Immunoassay Test Volume andDiagnostics Sales Forecast By Test CategoryU.S.A., Laboratories Performing Chemistry and Immunoassay Testing By Market SegmentU.S.A., Hospital Laboratories Performing Chemistry and Immunoassay Tests By Bed SizeU.S.A., Commercial/Private Laboratories Performing Chemistry and Immunoassay Tests ByAnnual Test VolumeU.S.A., Total Chemistry and Immunoassay Specimen Volume ForecastU.S.A., All Market Segments, Specimen Volume Forecast By Test CategoryU.S.A., Total Clinical Chemistry and Immunoassay Test Volume Forecast By Test CategoryU.S.A., Routine Chemistry Test Volume Forecast By Market SegmentU.S.A., TDM Test Volume Forecast By Market SegmentU.S.A., Endocrine Function Test Volume Forecast By Market SegmentU.S.A., Drugs of Abuse Test Volume Forecast By Market SegmentU.S.A., Tumor Markers and Special Chemistry Test Volume Forecast By Market SegmentU.S.A., Immunoprotein Test Volume Forecast By Market SegmentU.S.A., All Market Segments, Profiles, Panels and Individual Tests ForecastU.S.A., Hospital Laboratories, Profiles, Panels and Individual Tests ForecastU.S.A., Commercial/Private Laboratories, Profiles, Panels and Individual Tests ForecastU.S.A., Physician Offices/Group Practices, Profiles, Panels and Individual Tests ForecastU.S.A., All Market Segments, Routine Chemistry Test Volume Forecast by AssayU.S.A., Hospital Laboratories, Routine Chemistry Test Volume Forecast by AssayU.S.A., Commercial/Private Laboratories, Routine Chemistry Test Volume Forecast by AssayU.S.A., Physician Offices/Group Practices, Routine Chemistry Test Volume Forecast by AssayU.S.A., All Market Segments, TDM Test Volume Forecast by Assay
  • 9. U.S.A., Hospital Laboratories, TDM Test Volume Forecast by AssayU.S.A., Commercial/Private Laboratories, TDM Test Volume Forecast by AssayU.S.A., Physician Offices/Group Practices, TDM Test Volume Forecast by AssayU.S.A., All Market Segments, Endocrine Function Test Volume Forecast by AssayU.S.A., Hospital Laboratories, Endocrine Function Test Volume Forecast by AssayU.S.A., Commercial/Private Laboratories, Endocrine Function Test Volume Forecast by AssayU.S.A., Physician Offices/Group Practices, Endocrine Function Test Volume Forecast by AssayU.S.A., All Market Segments, Drugs of Abuse Test Volume Forecast by AssayU.S.A., Hospital Laboratories, Drugs of Abuse Test Volume Forecast by AssayU.S.A., Commercial/Private Laboratories, Drugs of Abuse Test Volume Forecast by AssayU.S.A., Physician Offices/Group Practices, Drugs of Abuse Test Volume Forecast by AssayU.S.A., All Market Segments, Tumor Markers and Special Chemistry Test Volume Forecast byAssayU.S.A., Hospital Laboratories, Tumor Markers and Special Chemistry Test Volume Forecast byAssayU.S.A., Commercial/Private Laboratories, Tumor Markers and Special Chemistry Test VolumeForecast by AssayU.S.A., Physician Offices/Group Practices, Tumor Markers and Special Chemistry Test VolumeForecast by AssayU.S.A., All Market Segments, Immunoprotein Test Volume Forecast by AssayU.S.A., Hospital Laboratories, Immunoprotein Test Volume Forecast by AssayU.S.A., Commercial/Private Laboratories, Immunoprotein Test Volume Forecast by AssayU.S.A., Physician Offices/Group Practices, Immunoprotein Test Volume Forecast by AssayU.S.A., Total Clinical Chemistry and Immunoassay Reagent Market Forecast By Test CategoryU.S.A., Clinical Chemistry and Immunoassay Calibrator and Control Market Forecast By TestCategoryU.S.A., Routine Chemistry Reagent Market Forecast By Market SegmentU.S.A., TDM Reagent Market Forecast By Market SegmentU.S.A., Drugs of Abuse Reagent Market Forecast By Market SegmentU.S.A., Tumor Markers and Special Chemistry Reagent Market Forecast By Market SegmentU.S.A., Endocrine Function Reagent Market Forecast By Market SegmentU.S.A., All Market Segments, Routine Chemistry Reagent Market Forecast by AssayU.S.A., Hospital Laboratories, Routine Chemistry Reagent Market Forecast by AssayU.S.A., Commercial/Private Laboratories, Routine Chemistry Reagent Market Forecast by AssayU.S.A., Physician Offices/Group Practices, Routine Chemistry Reagent Market Forecast by AssayU.S.A., All Market Segments, TDM Reagent Market Forecast by AssayU.S.A., Hospital Laboratories, TDM Reagent Market Forecast by AssayU.S.A., Commercial/Private Laboratories, TDM Reagent Market Forecast by AssayU.S.A., Physician Office/Group Practices, TDM Reagent Market Forecast by AssayU.S.A., All Market Segments, Drugs of Abuse Reagent Market Forecast by AssayU.S.A., Hospital Laboratories, Drugs of Abuse Reagent Market Forecast by AssayU.S.A., Commercial/Private Laboratories, Drugs of Abuse Reagent Market Forecast by Assay
  • 10. U.S.A., Physician Offices/Group Practices, Drugs of Abuse Reagent Market Forecast by AssayU.S.A., All Market Segments, Endocrine Function Reagent Market Forecast by AssayU.S.A., Hospital Laboratories, Endocrine Function Reagent Market Forecast by AssayU.S.A., Commercial/Private Laboratories, Endocrine Function Reagent Market Forecast by AssayU.S.A., Physician Offices/Group Practices, Endocrine Function Reagent Market Forecast byAssayU.S.A., All Market Segments, Tumor Markers and Special Chemistry Reagent Market Forecast byAssayU.S.A., Hospital Laboratories, Tumor Markers and Special Chemistry Reagent Market Forecast byAssayU.S.A., Commercial/Private Laboratories, Tumor Markers and Special Chemistry Reagent MarketForecast by AssayU.S.A., Physician Offices/Group Practices, Tumor Markers and Special Chemistry Reagent MarketForecast by AssayU.S.A., All Market Segments, Immunoprotein Reagent Market ForecastU.S.A., Hospital Laboratories,Immunoprotein Reagent Market Forecast ImmunoproteinU.S.A., Commercial/Private Laboratories, Immunoprotein Reagent Market ForecastU.S.A., Physician Offices/Group Practices, Immunoprotein Reagent Market Forecast by AssayU.S.A., Major Suppliers of Clinical Chemistry Reagents, Estimated Sales and Market SharesU.S.A., Major Suppliers of Clinical Chemistry Analyzers, Estimated Instrument Sales and MarketSharesU.S.A., Major Suppliers of Clinical Chemistry Diagnostics Products, Estimated Sales and MarketSharesU.S.A., Major Suppliers of Immunoassay Reagents, Estimated Sales and Market SharesU.S.A., Major Suppliers of Immunoassay Analyzers, Estimated Instrument Sales and MarketSharesU.S.A., Major Suppliers of Immunoassay Diagnostics Products, Estimated Sales And MarketSharesContact: sales@reportsandreports.com for more information.